London Daily

Focus on the big picture.
Friday, Oct 09, 2026

Regulators Are Cracking Down On People Trying To Sell Coronavirus Antibody Tests

“I think we should expect to see companies continue to pop up selling unproven, and in some cases probably just bad, testing,” a former FDA lawyer said.

As coronavirus antibody tests flood the market, regulators are accusing some sellers of taking advantage of people’s desperation to learn if they’ve already been infected.

In the last two weeks, state and local regulators have issued cease-and-desist orders to people and businesses selling COVID-19 antibody tests in Southern California, Las Vegas, and New Mexico, on the grounds that they were illegally advertising or processing these tests. Health officials in Kansas have also intervened to block a hospital from falsely claiming the tests could diagnose the disease.

The tests, which reveal the presence of antibodies that presumably protect you against reinfection, are being touted as a key tool for reopening the US economy and for identifying just how many people have actually been infected. Almost none of the antibody tests currently available in the US have been verified by the FDA, and health care providers across the country are being forced to choose which tests to offer with very little information about their accuracy.

Many providers are selling manufacturers’ tests with the proper caveats, making it clear to customers that they aren’t FDA-approved and they may not be accurate. But as demand for the tests skyrockets, other sellers are making false claims, leading state and local regulators to play whack-a-mole.

Following a growing number of local reports about misleading claims, the FDA on Tuesday warned health care providers that antibody tests should not be used to diagnose whether someone currently has the virus.

“I think we should expect to see companies continue to pop up selling unproven, and in some cases probably just bad, testing,” Patti Zettler, an assistant law professor at Ohio State University and a former attorney at the FDA, told BuzzFeed News by email. “There’s a market to take advantage of because we all, of course, want testing.”

In Dickinson County, Kansas, an hour west of Topeka, Herington Municipal Hospital has gotten into trouble with health officials for the way it’s been advertising its antibody tests. These tests “will not only tell you if you have the active virus but will also tell you if you have immunity,” the hospital posted on its website and Facebook page last week.

In fact, according to the FDA, no blood antibody tests have been proven capable of telling if a person currently has the virus, unlike nasal- and throat-swab diagnostic tests. Scientists also do not know definitively whether, or for how long, antibodies protect a person from getting reinfected.

County and state health officials in Kansas have asked Herington to stop selling the tests, saying that its claims were causing confusion and leading people to mistakenly believe they were infectious, the Abilene-Reflector Chronicle, a local newspaper, reported Monday.

“They are creating a lot of misinformation in the county and it is having repercussions outside our county,” Brian Holmes, Dickinson County’s health officer, told the paper. The county and the hospital did not return BuzzFeed News’ requests for comment.

Last week on a college campus in Cardiff, California, a drive-thru clinic called the COVID Clinic was ordered to stop operating by San Diego County. The county health agency said it failed to provide “necessary credentials and certifications required by State law in order to conduct the tests” and therefore “may not be producing reliable and verifiable results.”

The COVID Clinic has updated its website to say it was offering tests in Orange County. Matthew Abinante, a physician behind the clinic, did not return a request for comment. The California Department of Public Health did not respond to a request for comment about whether they could operate elsewhere in the state.

Also last week, the Nevada Department of Health and Human Services issued a cease-and-desist order to Sahara West Urgent Care & Wellness in Las Vegas for allegedly operating an “unlicensed laboratory.” It was also reportedly selling antibody tests with the false claim that they could test for a current infection.

The state agency noted in a press release that such “tests are not to be used for diagnostic purposes” and that any antibody test sold by the clinic “would not have a definitive result for the purposes of diagnosing COVID-19.”

A Sahara West representative expressed frustration to the Las Vegas Review-Journal, claiming that it had sought the state’s guidance early on. “We haven’t got much help or clarity from anyone,” spokesperson Andrew Mann said. “And now they’re telling us to stop.” The clinic did not return a request for comment.

And earlier this month, the New Mexico Attorney General issued a cease-and-desist to a woman, Chelsie McGuire, who was using Facebook to advertise COVID-19 antibody tests that she allegedly claimed could produce results in 10 minutes. McGuire was ordered to stop advertisements that make “scientifically unfounded claims” about coronavirus testing, the attorney general said in its notice to her, which also noted that she was not on the state’s list of testing sites. McGuire declined to comment to BuzzFeed News.

At the same time, it’s not always clear, for sellers or consumers, which of these tests can be relied on.

There are now over 110 antibody tests that the FDA has allowed to go to market without having their accuracy claims verified by the agency, part of an effort to quickly increase the number of tests available during the crisis. Only four companies’ tests have received official “emergency use authorization” from the FDA, indicating that their accuracy claims have been independently checked by the agency.

While the FDA is currently choosing to allow most antibody tests to go to market without any federal verification, states might have their own certification requirements or take action under general laws meant to prohibit deceptive business practices. “This means requirements may differ from state to state - and we might for that reason expect to see some variation,” Zettler said.

All those factors make it easier for companies with dishonest claims or credentials to try to capitalize on the moment. As the virus continues to spread, more bad actors will likely emerge and hamper badly needed attempts to bring the pandemic under control, said Steven Joffe, a bioethicist at the University of Pennsylvania.

“To get past this crisis, at least until we have a vaccine or highly effective treatments, we are going to need widespread testing,” Joffe said by email. “But for widespread testing to work, the public is going to have to trust in that testing. Particularly at this moment of threat and division, public trust is a fragile thing. Scammers are going to make it impossible to achieve.”

Newsletter

Related Articles

0:00
0:00
Close
UK and Germany Finalize Kensington Treaty to Strengthen Defense and Technology Cooperation
Britain Maintains Diplomatic Mission in East Jerusalem Despite Israeli Closure Deadline
English Councils Push Government to Rethink Proposed Funding Cuts
Scottish Homebuilding Falls to Lowest Level in 11 Years
BBC Chief Matt Brittin Defends Restructuring as Staff Challenge Job Cuts
UK Finance Warns High Energy Costs and Bond Yields Are Complicating Fiscal Outlook
UK Adopts All 44 Recommendations on Regulating AI in Healthcare
Chancellor John Healey Prepares Autumn Budget as Borrowing Costs Strain Public Finances
UK Investigators See Strong Indications of Iranian Link After RAF Fairford Security Operation
Laura Trott Pledges Tighter Controls on Political Activism in UK Classrooms
Welsh Ministers Launch Long-Term Review of North Wales and Anglesey Crossings
Welsh Government Orders 18-Month Study of Road Solutions Around Newport
Reform UK MP Sarah Pochin Faces Scrutiny Over £800,000 Second Home Purchase
British Households Grow More Concerned About Fuel and Energy Prices
NHS Leaders Warn of Rising Winter Pressure on Emergency Departments
Kemi Badenoch Proposes £2.3 Billion Employer National Insurance Cut for Young Workers
Middle East Conflict Could Erase UK Fiscal Headroom, Economists Warn
Manchester City Found Guilty of Multiple Premier League Financial Rule Breaches
UK Security Services Find Strong Indications of Iranian Role in RAF Fairford Incident
Costa Coffee Returns to Operating Profit on Iced Drinks and Menu Changes
Asos Warns Customers After Unauthorized Access to Retail App and Data
Kemi Badenoch Puts Growth and Deregulation at Center of Conservative Conference
Campaigners Warn of Deepening Social Care Crisis for Disabled Adults
Study Finds Rising Early-Onset Cancer Rates Among Adults Under 50 in Britain
UK Coach Operators Warn High Diesel Prices Could Force Route Cuts
FCA Opens Independent Review Into Handling of Epstein-Linked Whistleblower Case
Argentina Vows to Block Falkland Islands Offshore Oil Development
UK Chancellor Prepares Fiscal Measures and Welfare Reforms Ahead of Autumn Budget
Sainsbury’s and Morrisons Explore Potential Multi-Billion-Pound Merger
UK Weighs Tariffs on Chinese Electric Vehicles to Align With European Union
UK Threatens Diplomatic Expulsions Over Planned Closure of East Jerusalem Consulate
UK Energy Price Cap Hits Three-Year High as Middle East Conflict Raises Costs
Seventh Arrest Made in Suspected Terror Plot at RAF Fairford
Systemic Education Collapse Sparks Mass Student Uprisings in France
Green Party Faces Backlash Over Resolution Equating Zionism With Racism
Conservatives Debate Scrapping Environmental Rules for New Homes
Cornwall Insight Warns UK Energy Bills Could Approach £2,000 This Winter
UK Coach Operators Warn of Service Cuts as Diesel Prices Exceed £2
Scottish Parliament Approves £68 Billion Budget With New Tax and Property Measures
FCA Opens Independent Review Into Handling of Epstein Whistleblower
UK Government Drops Plan to Suspend Jury Trials in England and Wales
Bank of England Holds Interest Rate at 3.75% as Markets Watch November
Two Iranian Nationals Charged Over Alleged Plot Targeting Manchester Jewish Community
UK Fiscal Headroom Halves to £11 Billion Ahead of Budget, EY Warns
US Bomber Withdrawal From RAF Fairford Prompts UK Security Review
Sarah Wakfer Appointed Chair of Northern Ireland’s Health and Care Regulator
Scotland Housing Completions Fall to 11-Year Low Amid National Shortage
UK Water Companies Face Tougher Oversight and Unannounced Regulatory Inspections
Middle East Conflict Pushes UK Fuel and Wholesale Energy Prices Higher
Andy Burnham Raises Prospect of Second Brexit Referendum in Review of UK-EU Relations
×